Boris Minev
Chief Tech/Sci/R&D Officer at CALIDI BIOTHERAPEUTICS, INC.
Net worth: 67 913 $ as of 2024-04-29
Profile
Boris Minev is currently the Chief Medical Officer & President-Medical Affairs at Calidi Biotherapeutics, Inc. He previously worked as the Director-Immunotherapy & Translational Oncology at Genelux Corp.
from 2010 to 2015, and as the Director-Tumor Immunology & Immunotherap at UCSD Moores Cancer Center from 2000 to 2015.
Dr. Minev holds a doctorate degree from Medical University Sofia.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-25 | 424,458 ( 1.19% ) | 67 913 $ | 2024-04-29 |
Boris Minev active positions
Companies | Position | Start |
---|---|---|
CALIDI BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Boris Minev
Companies | Position | End |
---|---|---|
GENELUX CORPORATION | Corporate Officer/Principal | 2015-05-31 |
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of California, UCSD Moores Cancer Center provides clinical and medical research services for cancer treatment. The company is based in La Jolla, CA. | Corporate Officer/Principal | 2015-05-31 |
Training of Boris Minev
Medical University Sofia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GENELUX CORPORATION | Health Technology |
CALIDI BIOTHERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of California, UCSD Moores Cancer Center provides clinical and medical research services for cancer treatment. The company is based in La Jolla, CA. | Commercial Services |
- Stock Market
- Insiders
- Boris Minev